Proteinuria as a surrogate marker for renal outcome: Are we there yet?

Kidney International

Volumn 88, Issue 6, 2015, Pages 1228-1230

  Avasare, Rupali S ^a   Radhakrishnan, Jai ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MARKER; GLOMERULOPATHY; HUMAN; KIDNEY FUNCTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RELIABILITY; REVIEW;

EID: 84949870925     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.301     Document Type: Note

References (9)

1. Peterson JC, Adler S, Burkart JM et al. Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762
2. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183
3. Thompson A, Cattran DC, Blank M et al. Complete and partial remission as surrogate end points in membranous nephropathy. J Am Soc Nephrol (advance online publication on 15 June 2015, doi: 10.1681/asn.2015010091)
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S76-S110
5. Barbour SJ, Cattran DC, Espino-Hernandez G et al. Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis. Kidney Int 2002; 88: 1392-1401
6. Troyanov S, Wall CA, Miller JA et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 2005; 16: 1061-1068
7. Gipson DS, Trachtman H, Kaskel FJ et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 2011; 80: 868-878
8. Lv J, Zhang H, Chen Y et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 2009; 53: 26-32
9. Hofstra JM, Branten AJ, Wirtz JJ et al. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial. Nephrol Dial Transplant 2010; 25: 129-136.